Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Luque, Raul M ^a,b,c   Lin, Qing ^a,b   Córdoba Chacón, José ^c   Subbaiah, Papasani V ^b   Buch, Thorsten ^d   Waisman, Ari ^e   Vankelecom, Hugo ^f   Kineman, Rhonda D ^a,b  

^a JESSE BROWN VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CÓRDOBA   (Spain)

^d INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GLUCOSE; GROWTH HORMONE; INSULIN; LEPTIN; PROLACTIN; TESTOSTERONE; THYROID HORMONE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; SIGNAL PEPTIDE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CALORIMETRY; CELL DESTRUCTION; CONTROLLED STUDY; DISEASE COURSE; ENERGY METABOLISM; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING CELL; HORMONE METABOLISM; HYPOPHYSIS CELL; INSULIN SENSITIVITY; LIPID STORAGE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUTRITIONAL STATUS; ONSET AGE; ADENOHYPOPHYSIS; ANIMAL; CARBOHYDRATE METABOLISM; DIET; DISEASE MODEL; GENETICS; INSULIN RESISTANCE; METABOLISM; MOUSE MUTANT; RAT;

MUS; RATTUS;

AGE OF ONSET; ANIMALS; CARBOHYDRATE METABOLISM; DIET; DISEASE MODELS, ANIMAL; ENERGY INTAKE; ENERGY METABOLISM; GROWTH HORMONE; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, MUTANT STRAINS; PITUITARY GLAND, ANTERIOR; RATS; SOMATOTROPHS;

EID: 79251638798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015767     Document Type: Article

References (50)

1. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19: 717-797.
2. Scacchi M, Pincelli AI, Cavagnini F (1999) Growth hormone in obesity. Int J Obes Relat Metab Disord 23: 260-271.
3. Vijayyakumar A, Navosyadlyy R, Wu Y, Yakar S, LeRoith D (2009) Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 20: 1-7.
4. Attallah H, Friedlander AL, Hoffman AR (2006) Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Horm IGF Res 16: 62-67.
5. Giovannini S, Marzetti E, Borst SE, Leeuwenburgh C (2008) Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults. Mech Age Dev 129: 593-601.
6. Hersch EC, Merriam GR (2008) Growth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of youth or pool of Tantalus. Clin Interv Aging 3: 121-129.
7. Luque RM, Amargo G, Ishii S, Lobe C, Franks R, et al. (2007) Reporter expression, induced by a GH promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland. Endocrinology 148: 1946-1953.
8. Buch T, Heppner FL, Tertilt C, Heinen TJ, Kremer M, et al. (2005) A Creinducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2: 419-426.
9. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034.
10. Bligh DG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
11. Riachi M, Himms-Hagen J, Harper M (2004) Percent relative cumulative frequency analysis in indirect calorimetry: application to studies of transgenic mice. Can J Physiol Pharmacol 82: 1075-1083.
12. Kappeler L, De Magalhaes Filho C, Leneuve P, Xu J, Brunel N, et al. (2009) Early postnatal nutrition determines somatotropic function in mice. Endocrinology 150: 314-323.
13. Luque RM, Kineman RD (2006) Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function. Endocrinology 147: 2754-2763.
14. Luque RM, Kineman RD, Tena-Sempere M (2007) Regulation of hypothalamic expression of KiSS-1 and GPR54 genes by metabolic factors: Analyses using mouse models and a cell line. Endocrinology 148: 4601-4611.
15. Imrie H, Abbas A, Viswambharan H, Rajwani A, Cubbon RM, et al. (2009) Vascular insulin-like growth factor-I resistance and diet-induced obesity. Endocrinology 150: 4575-4582.
16. Venken K, Moverare-Skrtic S, Kopchick JJ, Coschigano KT, Ohlsson C, et al. (2007) Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. J Bone Min Res 22: 72-82.
17. Williams TD, Chambers JB, Roberts LM, Henderson RP, Overton JM (2003) Diet-induced obesity and cardiovascular regulation in C57Bl/6J mice. Clin Expt Pharmacol Physiol 30: 769-778.
18. Bjursell M, Gerdin AK, Lelliott CJ, Egecioglu E, Elmgren A, et al. (2008) Acutely reduced locomotor activity is a major contributor to Western dietinduced obesity in mice. Am J Physiol Endocrinol Metab 294: E251-E260.
19. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D (2002) Increased insulin sensitivity and upregulation of insulin-receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol 173: 81-94.
20. Liu J-L, Coschigano KT, Robertson K, Lipsett M, Guo Y, et al. (2004) Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am J Physiol Endocrinol Metab 287: E405-E413.
21. Del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, et al. (2007) Growth hormone regulation of p85a expression and phosphoinositide 3-kinase activity in adipose a tissue. Diabetes 56: 1638-1646.
22. Jorgensen JO, Krag M, Jessen N, Norrelund H, Vestergaard ET, et al. (2004) Growth hormone and glucose homeostasis. Horm Res 62: 51-55.
23. Lanes R (2004) Metabolic abnormalities in growth hormone deficiency. Pediatr Endocrinol Rev 2: 209-215.
24. Groop L, Segerlantz M, Bramnert M (2005) Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment. Horm Res 64: 45-50.
25. Menezes Oliveira JL, Marques-Santos C, Barreto-Filho JA, Ximenes Filho R, de Oliveira Britto AV, et al. (2006) Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GHreleasing hormone receptor mutation. J Clin Endocrinol Metab 91: 2093-2099.
26. Pereira RMC, Aguiar-Oliveira MH, Sagazio A, Oliveira CRP, Oliveira FT, et al. (2007) Heterozygosity for a mutation in the growth hormone-releasing hormone receptor gene does not influence adult stature, but affects body composition. J Clin Endocrinol Metab 92: 353-2357.
27. Kanety H, Hemi R, Ginsberg S, Pariente C, Yissachar E, et al. (2009) Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. Eur J Endocrinol 161: 837-844.
28. Christ ER, Simpson HL, Breen L, Sonksen PH, Russell-Jones DL, et al. (2003) The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes melllitus and GH deficiency. Clin Endocrinol 58: 309-315.
29. Yuen KCJ, Dunger DB (2007) Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults. Diabetes Obes Metab 9: 11-22.
30. Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC (2003) Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults. Eur J Endocrinol 149: 511-519.
31. Sagerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC (2001) Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults. J Clin Endocrinol Metab 86: 5813-5818.
32. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, et al. (2004) Inhibition of growth hormone action improves insulin sensitivity in liver IGF-I-deficient mice. J Clin Invest 113: 96-105.
33. Boyle PJ, Avogaro A, Smith L, Shah SD, Cryer PE, et al. (1992) Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia 35: 372-379.
34. Sasaki-Suzuki N, Arai K, Ogata T, Kasahara K, Sakoda H, et al. (2009) Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 284: 6061-6070.
35. Short KR, Moller N, Bigelow ML, Coenen-Schimke J, Nair KS (2008) Enhancement of muscle mitochondrial function by growth hormone. J Clin Endocrinol Metab 93: 597-604.
36. Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, et al. (2000) Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85: 1686-1694.
37. Luque RM, Park S, Kineman RD (2007) Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone (GHRH) in the fasted mouse; potential role of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Endocrinology 148: 300-309.
38. Loh DH, Abad C, Colwell CS, Waschek JA (2008) Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids. Neuroendocrinology 88: 246-255.
39. Guo Y, Lu Y, Houle D, Robertson K, Tang Z, et al. (2005) Pancreatic isletspecific expression of an insulin-like growth factor-I transgene compensates islet cell growth in growth hormone receptor gene-deficient mice. Endocrinology 146: 2602-2609.
40. Lindberg K, Ronn SG, Tornehave D, Richter H, Hansen JA, et al. (2005) Regulation of pancreatic β-cell mass and proliferation by SOCS-3. J Mol Endocrinol 35: 231-243.
41. Nielsen JH, Moldrup A, Billestrup N (1990) Expression of the growth hormone receptor gene in insulin producing cells. Biomed Biochem Acta 49: 1151-1155.
42. Delehaye-Zervas MC, Mertani H, Martini JF, Nihoul-Fekete C, Morel G, et al. (1994) Expression of the growth hormone receptor gene in human digestive tissue. J Clin Endocrinol Metab 78: 1473-1480.
43. Nielsen JH, Linde S, Welinder BS, Billestrup N, Madsen OD (1989) Growth hormone is a growth factor for the differentiated pancreatic β-cell. Mol Endocrinol 3: 165-173.
44. Jensen J, Galsgaard ED, Karlsen AE, Lee YC, Nielsen JH (2005) STAT5 activation by human GH protects insulin-producing cells against interleukin-1β, interferon-γ and tumour necrosis factor-α-induced apoptosis independent of nitric oxide production. J Endocrinol 187: 25-36.
45. Yuen KCJ, Dunger DB (2006) Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults. Growth Horm IGF Res 6: S55-S61.
46. Rosenfalck AM, Maghsoudi S, Fisker S, Jorgensen JOL, Christiansen JS, et al. (2000) The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab 85: 4173-4181.
47. Trimble ER, Atkinson AB, Buchanan KD, Hadden DR (1980) Plasma glucagon and insulin concentrations in acromegaly. J Clin Endocrinol Metab 51: 626-631.
48. Cui Y, Hosui A, Sun R, Shen J, Gavrilova O, et al. (2007) Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 4: 504-513.
49. Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, et al. (2009) Liver-specific deletion of the growth hormone receptor reveals essential role of GH signaling in hepatic lipid metabolism. J Biol Chem 284: 19937-19944.
50. Frick F, Bohlooly Y, Linden D, Olsson B, Tornell J, et al. (2001) Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab 281: E1230-E1239.